新心脏分配时代同期心肾移植受者生存率下降
该研究基于UNOS数据库纳入2012至2021年登记行同期心肾移植的成人患者,比较新旧分配政策时代(2012-2018年 vs 2019-2021年)的等待名单与移植后结局。新政策时代移植可能性增加、等待名单死亡率下降,但移植后2年生存率降低,总体生存率亦降低。
要点
- 新政策时代移植可能性增加(aSHR 1.52,p<0.01),等待名单死亡率下降(aSHR 0.63,p<0.01)。
- 新政策时代移植后2年生存率降低(78.8% vs 86.9%,p<0.01)。
- 偏小心脏(HR 2.02,p<0.01)、使用ECMO(HR 2.67,p<0.1)及政策变更后移植(HR 1.45,p=0.03)与死亡风险增加相关。
核心结论
- 分配政策变更改善了同期心肾移植登记患者的等待名单结局,但可能以移植后结局恶化为代价。
研究设计与样本
- 回顾性队列研究,纳入2012至2021年登记行同期心肾移植的成人患者,跨胸科与肾脏UNOS数据库交叉验证,按登记时代分层。
主要发现
- 共纳入2588例患者,其中2012-2018年(时代1)登记1406例(54.1%),2019-2021年(时代2)登记1182例(45.9%)。
- 时代2移植可能性增加(aSHR 1.52,p<0.01),等待名单死亡率下降(aSHR 0.63,p<0.01)。
- 移植后2年生存率时代2降低(78.8% vs 86.9%,p<0.01)。
- 偏小心脏(HR 2.02,p<0.01)、使用ECMO(HR 2.67,p<0.1)及政策变更后移植(HR 1.45,p=0.03)与死亡风险增加相关。
- 总体生存率(合并等待名单与移植后)现代时代显著降低(71.6% vs 62.2%,p=0.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2018, the United Network for Organ Sharing (UNOS) modified their heart allocation policy to reduce waitlist mortality. The rates of simultaneous heart-kidney transplant (SHKT) have dramatically increased in recent years, despite increased rates of posttransplant renal failure in the new policy era. This study sought to investigate the impact of the new allocation system on waitlist and posttransplant outcomes of simultaneous heart-kidney transplantation. METHODS: Adult patients listed for SHKT between 2012 and 2021 were included. Patients were cross-validated across both Thoracic and Kidney UNOS databases to confirm accurate listing and transplant data. Patients were stratified according to listing era. The Fine and Gray model was used to assess waitlist outcomes and posttransplant renal graft function. Kaplan-Meier analysis and Cox regression were used to compare posttransplant survival. RESULTS: A total of 2,588 patients were included, of whom 1,406 (54.1%) were listed between 2012 and 2018 (era 1) and 1,182 (45.9%) between 2019 and 2021 (era 2). Era 2 was associated with increased likelihood of transplant (adjusted Sub-hazard ratios (aSHR): 1.52; p < 0.01) and decreased waitlist mortality (aSHR: 0.63; p < 0.01). Posttransplant survival at 2 years was decreased in era 2 (78.8% vs 86.9%; p < 0.01). Undersized hearts (hazard ratio [HR]: 2.02; p < 0.01), use of extracorporeal membrane oxygenation (HR: 2.67; p < 0.1), and transplants performed following the policy change (HR: 1.45; p = 0.03) were associated with increased mortality. Actuarial survival (combined waitlist and posttransplant) was significantly lower in the modern era (71.6% vs 62.2%; p = 0.02). CONCLUSIONS: The allocation policy change has improved waitlist outcomes in patients listed for SHKT but potentially at the cost of worsened posttransplant outcomes.
引用
- Shin M, Iyengar A, Helmers MR, et al. Decreased survival of simultaneous heart-kidney transplant recipients in the new heart allocation era. J Heart Lung Transplant. 2023. PMID: 37579829. doi:10.1016/j.healun.2023.08.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。